Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2024 06:00 ET | Source: Tome Biosciences

Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT

Tome presented data updates on its programmable genomic integration technologies at ASGCT.
April 23, 2024 08:00 ET | Source: Tome Biosciences

Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT

Tome to present data at ASGCT.
April 09, 2024 08:08 ET | Source: Tome Biosciences

Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration

Tome granted US patent for programmable genomic integration.
March 04, 2024 08:00 ET | Source: Tome Biosciences

Tome Biosciences Forms Science and Technology Advisory Committee

Tome forms Science and Technology Advisory Committee.
January 30, 2024 08:00 ET | Source: Tome Biosciences

Tome Biosciences Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors

Tome Biosciences appoints Daniel Curran, MD, to its Board of Directors.
January 02, 2024 09:00 ET | Source: Tome Biosciences

Tome Biosciences Acquires Replace Therapeutics

Tome acquires Replace Therapeutics.
December 12, 2023 07:57 ET | Source: Tome Biosciences

Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform

Tome Biosciences launches with over $200 million in funding to advance programmable genomic integration (PGI).